Humira profits can't save tough quarter for AbbVie

By Jaimy Lee  |  January 30, 2015

A 10.6% increase in sales of its top-selling arthritis drug Humira still couldn't produce positive fourth-quarter earnings for drugmaker AbbVie, the Chicago-based spinoff of Abbott Laboratories.

White House proposes $215 million, new regs for precision medicine

White House proposes $215 million, new regs for precision medicine

By Darius Tahir  |  January 30, 2015

The White House is proposing $215 million in new funds and new regulations in a sweeping effort involving the NIH, the FDA and the ONC to help fulfill the promise of what President Barack Obama has termed precision medicine.

Tamiflu controversy reignited by new study

By Sabriya Rice  |  January 29, 2015

The antiviral medication Tamiflu shortened the length of time patients experienced flu symptoms, and reduced rates of complications and hospitalizations from the virus, a new study finds. But it did not have an effect on those with flu-like symptoms who did not have the flu.

Harvard Pilgrim secures discount on Gilead's newest hep C drug

By Bob Herman  |  January 29, 2015

Harvard Pilgrim Health Care, one of the largest not-for-profit health insurers in New England, said it will save millions of dollars in hepatitis C drug costs through its negotiated pricing discount from pharmaceutical giant Gilead Sciences.

FDA getting quicker at reviewing new drugs, study participants say

By Steven Ross Johnson  |  January 28, 2015

Pharmaceutical industry leaders indicate the federal government's review process for the approval of new drugs and medical devices has improved in recent years, according to new report. But questions remain regarding whether changes to the regulatory process are needed to ensure quicker release of...

CMS  can order trials before OKing payment for new tech

CMS can order trials before OKing payment for new tech

By Virgil Dickson  |  January 24, 2015

The CMS will continue ordering some drug and device manufacturers to collect evidence on how well their technologies work before giving its final approval on reimbursement.

Guest commentary: Pharmacy will play key roles in healthcare evolution

Guest commentary: Pharmacy will play key roles in healthcare evolution

By Chuck Ball  |  January 23, 2015

In today's reform environment, the roles of pharmacy and pharmacists are constantly changing, so it's no surprise that the year ahead is likely to present health-system pharmacies with new opportunities, along with elevated responsibilities and risks. Pharmacy leaders will play an even more...

Experts see value in stronger oversight of compounded drugs in hospitals

By Lisa Schencker  |  January 23, 2015

New recommendations on how to improve the safety of compounded, sterile drugs given in hospitals represent a step forward in the fight to prevent more patients from being sickened or killed by mishandled or improperly compounded drugs, experts say.

Ebola vaccine tests to begin in West Africa

By Steven Ross Johnson  |  January 22, 2015

Long-awaited trials to test two potential vaccines against the Ebola virus will begin in West Africa within the next few weeks, U.S. health officials said Thursday.

CMS urged to step up oversight of compounded drugs

By Lisa Schencker  |  January 22, 2015

Significant gaps remain in ensuring the safety of compounded drugs given in hospitals, reports a study released to Modern Healthcare early Thursday morning by HHS' Office of Inspector General.

Johnson & Johnson sees 28% drop in Q4 net income

By Jaimy Lee  |  January 20, 2015

Johnson & Johnson reported a 28% drop in net income and flat sales in the fourth quarter of 2014. The income falloff came about because of the impact of unfavorable currency fluctuations along with charges, including integration costs related to the 2012 acquisition of Synthes, and increased...

Modern Healthcare Daily

The top stories in healthcare business every day

The Modern Healthcare Daily News App provides you with registration-free access to the top trending healthcare business news. It's the only news you need each day.